D. E. Shaw & Co., Inc. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$1,855,000
-27.6%
581,446
-3.1%
0.00%0.0%
Q1 2022$2,563,000
-6.4%
600,070
+1.9%
0.00%0.0%
Q4 2021$2,738,000
+12.4%
588,802
-3.6%
0.00%0.0%
Q3 2021$2,437,000
-12.1%
610,654
-5.7%
0.00%0.0%
Q2 2021$2,772,000
-10.6%
647,528
-11.4%
0.00%
-33.3%
Q1 2021$3,100,000
+92.2%
731,137
+75.9%
0.00%
+200.0%
Q4 2020$1,613,000
+74.0%
415,736
+80.7%
0.00%0.0%
Q3 2020$927,000
+221.9%
230,097
+214.5%
0.00%
Q4 2019$288,000
-87.6%
73,167
-72.3%
0.00%
-100.0%
Q3 2019$2,322,000
+65.7%
263,869
+74.2%
0.00%
+50.0%
Q2 2019$1,401,000
-63.0%
151,440
-74.3%
0.00%
-60.0%
Q1 2019$3,785,000
-15.1%
588,621
+359.2%
0.01%
-28.6%
Q3 2017$4,458,000
+138.9%
128,184
+104.5%
0.01%
+133.3%
Q2 2017$1,866,000
-66.6%
62,680
-66.5%
0.00%
-70.0%
Q1 2017$5,586,000
+2116.7%
187,158
+1963.0%
0.01%
Q3 2015$252,000
-89.0%
9,072
-90.3%
0.00%
-100.0%
Q2 2015$2,295,000
-24.5%
93,635
-43.6%
0.00%
-40.0%
Q1 2015$3,040,000
+150.2%
166,114
+152.2%
0.01%
+150.0%
Q4 2014$1,215,00065,8780.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders